Références

Note : les liens hypertextes menant vers d'autres sites ne sont pas mis à jour de façon continue. Il est possible qu'un lien devienne introuvable. Veuillez alors utiliser les outils de recherche pour retrouver l'information désirée.

Bibliographie

American Cancer Society. Cancer Reference Information - Tamoxifen and Raloxifene to Reduce Breast Cancer Risk, American Cancer Society. [Consulté le 12 octobre 2004]. www.cancer.org
Ask DrWeil, Polaris Health (Ed). Daily Tip Discussions -Lifestyle Risks and Breast Cancer, DrWeil.com. [Consulté le 12 octobre 2004]. http://forums.drweil.com
Boik J. Cancer & Natural Medecine - A Textbook of Basic Science and Clinical Research, Oregon Medical Press (Princetown, MA), 1996.
Jellin JM, Gregory P, Batz F, Hitchens K, et al. Natural Medicines Comprehensive Database, 3rd Ed. Therapeutic Research Faculty (Stockton, CA), 2000.
InteliHealth (Ed). Diseases and Conditions - Breast Cancer, Aetna Intelihealth. [Consulté le 12 octobre 2004]. www.intelihealth.com
Mayo Foundation for Medical Education and Research (Ed). Diseases & Conditions - Breast Cancer, MayoClinic.com. [Consulté le 12 octobre 2004]. www.mayoclinic.com
National Library of Medicine (Ed). PubMed, NCBI. [Consulté le 4 juin 2004]. www.ncbi.nlm.nih.gov
Santé Canada. Mise en garde/Avis - Le tamoxifène associé à un risque accru d'accident cérébrovasculaire, d'embolie pulmonaire et de cancer de l'utérus, Santé Canada en direct. [Consulté le 26 novembre 2002]. www.hc-sc.gc.ca/francais/
Willett, Walter C., M.D. Eat, Drink and Be Healthy, Simon & Shuster (New York), 2001.

Notes

1. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997;337(24):1705-14.
2. Crowell EB Jr, Jubelirer SJ. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results. W V Med J. 2000 Nov-Dec;96(6):598-601.
3. [No authors listed] Tamoxifen unsuitable for primary prevention of breast cancer: uncertain efficacy, clear risks. Prescrire Int. 2000 Apr;9(46):56-8.
4. Santé Canada. Mise en garde/Avis - Le tamoxifène associé à un risque accru d'accident cérébrovasculaire, d'embolie pulmonaire et de cancer de l'utérus, Santé Canada en direct. [Consulté le 26 novembre 2002]. www.hc-sc.gc.ca/francais/
5. Zhang S, Hunter DJ, Forman MR, Rosner BA, Speizer FE, Colditz GA, Manson JE, Hankinson SE, Willett WC. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst. 1999 Mar 17;91(6):547-56.
6. Slavin JL. Mechanisms for the impact of whole grain foods on cancer risk. J Am Coll Nutr. 2000 Jun;19(3 Suppl):300S-307S. Review.
7. Baghurst PA, Rohan TE. High-fiber diets and reduced risk of breast cancer. Int J Cancer. 1994 Jan 15;56(2):173-6.
8. Lipworth L, Martinez ME, Angell J, et al. Olive oil and human cancer: an assessment of the evidence. Prev Med. 1997 Mar-Apr;26(2):181-90.
9. Zhang S, Hunter DJ, Forman MR, et al. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst 1999;91(6):547-56.
10. White WS, Stacewicz-Sapuntzakis M, Erdman JW Jr, et al. Pharmacokinetics of beta-carotene and canthaxanthin after ingestion of individual and combined doses by human subjects. J Am Coll Nutr. 1994;13:665-671.
11. Flaxseed May Fight Breast Cancer In Postmenopausal Women, Health News, InteliHealth [Consulté le 7-09-2001] www.intelihealth.com
12. Seely D, Mills EJ, Wu P, Verma S, Guyatt GH. The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther. 2005 Jun;4(2):144-55. Review.
13. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst. 1999 Feb 17;91(4):317-31. Review.
14. Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL, Rosner BA, Colditz GA, Speizer FE, Willett WC.A prospective study of folate intake and the risk of breast cancer. JAMA. 1999;281:1632-1637.
15. Willett WC. Diet and cancer: one view at the start of the millennium. Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):3-8.
16. Breslow RA, Ballard-Barbash R, Munoz K, Graubard BI. Long-term recreational physical activity and breast cancer in the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):805-8.
17. Zheng T, Duan L, Liu Y, Zhang B, Wang Y, Chen Y, Zhang Y, Owens PH. Lactation reduces breast cancer risk in Shandong Province, China.Am J Epidemiol. 2000 Dec 15;152(12):1129-35.
18. Dorant E, van den Brandt PA, Goldbohm RA. Allium vegetable consumption, garlic supplement intake, and female breast carcinoma incidence.Breast Cancer Res Treat. 1995;33(2):163-70.
19. Kenny FS, Pinder SE, Ellis IO, et al. Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int J Cancer 2000; 85:643-648.
20. Upton R (ed). Astragalus Root: analytical, quality control, and therapeutic monograph. American Herbal Pharmacopoeia (Santa Cruz, CA). 1999.
21. Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun. 1994 Mar 30;199(3):1504-8.
22. Lund EL. Effect of radiation therapy on small cell lung cancer is reduced by ubiquinone intake. Folia Microbol. 1998;43:505-506.
23. Crespo D, Fernandez-Viadero C, Verduga R, Ovejero V, Cos S. Interaction between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cells. J Pineal Res. 1994 May;16(4):215-22.
24. Osborne M, Boyle P, Lipkin M. Cancer Prevention. Lancet 1997;349(suppl 2):27-30.
25. Lissoni P, Barni S, Mandala M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solic tumor patients with poor clinical status. Eur J Cancer 1999;35:1688-92.
27. Garcia JJ, Reiter RJ, Ortiz GG, Oh CS, et al. Melatonin enhances tamoxifen's ability to prevent the reduction in microsomal membrane fluidity induced by lipid peroxidation.J Membr Biol. 1998 Mar 1;162(1):59-65.
28. Pike MC, Ross RK. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids. 2000 Oct - Nov;65(10 -11):659-64.
29. Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG. Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol. 2001 May;97(5 Pt 2):855-66. Review.
30. Hjartaker A, Laake P, Lund E. Childhood and adult milk consumption and risk of premenopausal breast cancer in a cohort of 48,844 women - the Norwegian women and cancer study. Int J Cancer. 2001 Sep15;93(6):888-93.
31. « L'autoexamen des seins ne diminue pas la mortalité par cancer du sein. » L'Actualité Médicale. 17 octobre 2001.
32. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989 Oct 14;2(8668):888-91.
33. Willett, Walter C., M.D. Eat, Drink and Be Healthy, Simon & Shuster (New York), 2001.
34. Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, Lubin F, Marubini E, Modan B, Rohan T, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990 Apr 4;82(7):561-9
35. Boyd NF, Greenberg C, Lockwood G, Little L, Martin L, Byng J, Yaffe M, Tritchler D.Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst. 1997 Apr 2;89(7):488-96.
36. Terry P, Wolk A, Persson I, et al. Brassica vegetables and breast cancer risk [letter]. JAMA. 2001;286:2975-2977.
37. Fowke JH, Longcope C, Hebert JR. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(:773-9.
38. Rock CL, Flatt SW, Wright FA, Faerber S, Newman V, Kealey S, Pierce JP. Responsiveness of carotenoids to a high vegetable diet intervention designed to prevent breast cancer recurrence. Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(:617-23.
39. Hunter DJ, Spiegelman D, Adami HO, et al. Cohort studies of fat intake ans the risk of breast cancer - a pooled analysis. N England J Med. 1996 Feb 8;334(6):356-61.
40. Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, et al. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies.JAMA. 2001 Feb 14;285(6):769-76.
41. Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA. 2004 May 26;291(20):2433-40.
42. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A; Women's Health Initiative. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res. 2003 Sep 15;63(18):6096-101.
43. Folkers K, Brown R, Judy WV, Morita M. Survival of cancer patients on therapy with coenzyme Q10. Biochem Biophys Res Commun. 1993 Apr 15;192(1):241-5.
44. Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med. 1994;15 Suppl:s231-40.
45. Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Commun. 1995 Jul 6;212(1):172-7.
46. Hodges S, Hertz N, Lockwood K, Lister R. CoQ10: could it have a role in cancer management?Biofactors. 1999;9(2-4):365-70.
47. Ask DrWeil, Polaris Health (Ed). Daily Tip Discussions -Lifestyle Risks and Breast Cancer, DrWeil.com. [Consulté le 12 octobre 2004]. http://forums.drweil.com
48. American Cancer Society. Cancer Reference Information - Tamoxifen and Raloxifene to Reduce Breast Cancer Risk, American Cancer Society. [Consulté le 12 octobre 2004]. www.cancer.org
49. Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA. 2004 May 26;291(20):2433-40.
50. Mayo Foundation for Medical Education and Research (Ed). Diseases & Conditions - Breast Cancer, MayoClinic.com. [Consulté le 12 octobre 2004]. www.mayoclinic.com
51. Moorman PG, Terry PD. Consumption of dairy products and the risk of breast cancer : a review of the litterature. Am J Clin Nutr, 2004, 80, 5-14.
52. Santé Canada. Guide Canadien de médecine clinique préventive - Dépistage du cancer du sein, Santé Canada. [Consulté le 30 septembre 2005]. www.hc-sc.gc.ca
53. Berrington de González A, Reeves G. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits. British Journal of Cancer (2005) 93, 590-596.